US Patent 7,605,003. Use of biomarkers for detecting ovarian cancer. Inventors: Daniel Chan; Zhen Zhang; Eric Fung; Xiao-Ying Meng. Assignees: Johns Hopkins University; Vermillion

Pertains to a method of qualifiying ovarian cancer status in a patient. The method comprises measuring at least one biomarker in a sample from the patient, then correlating the measurement with ovarian cancer status. The invention also relates to kits for qualifying ovarian cancer status in a patient.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.